GLSI Greenwich LifeSciences
Greenwich LifeSciences earnings company data as of 4:48 AM ET 10/23
Limited consensus data for this ticker (thin coverage or data-plan limits).
Dates may be company-announced rather than sell-side consensus.
Calendar and recent prints remain the primary lens when available.
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 13 Nov | EPS | — | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by GLSI's executives, directors and 10% owners in the last 12 months, from their Form 4s
- $586K bought by 1 insider
- None no sales outside a trading plan
- None no planned (10b5-1) sales
-
Snehal Patel CEOBuy$30K 2,200 shares at $13.43 +<0.1% to stakeTraded Jul 28–29 Filed Jul 30
-
Snehal Patel CEOBuy$20K 1,500 shares at $13.62 +<0.1% to stakeTraded Jul 27 Filed Jul 29
-
Snehal Patel CEOBuy$47K 3,600 shares at $13.06 +0.1% to stakeTraded Jul 23–24 Filed Jul 27
-
Snehal Patel CEOBuy$54K 1,800 shares at $29.83 +<0.1% to stakeTraded Jan 13 Filed Jan 15
-
Snehal Patel CEOBuy$80K 2,900 shares at $27.54 +0.1% to stakeTraded Jan 12 Filed Jan 14
-
Snehal Patel CEOBuy$92K 4,300 shares at $21.36 +0.1% to stakeTraded Dec 31, 2025 Filed Jan 5
-
Snehal Patel CEOBuy$63K 2,900 shares at $21.73 +0.1% to stakeTraded Dec 30, 2025 Filed Jan 2
-
Snehal Patel CEOBuy$52K 4,100 shares at $12.62 +0.1% to stakeTraded Dec 18, 2025 Filed Dec 19, 2025
-
Snehal Patel CEOBuy$39K 4,600 shares at $8.37 +0.1% to stakeTraded Nov 25, 2025 Filed Nov 28, 2025
-
Snehal Patel CEOBuy$89K 10,600 shares at $8.43 +0.2% to stakeTraded Nov 7, 2025 Filed Nov 12, 2025
-
Snehal Patel CEOBuy$21K 2,300 shares at $9.26 +<0.1% to stakeTraded Oct 31, 2025 Filed Nov 4, 2025
SEC filings
Recent issuer filings from EDGAR, 12 shown.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.